[LETTERHEAD OF MPI RESEARCH] SERVICES AGREEMENT ADDENDUM No. 2

Contract Categories: Business Operations - Services Agreements
EX-10.14(B) 5 dex1014b.htm SERVICES AGREEMENT ADDENDUM NO. 2 DATED DECEMBER 31, 2004 Services Agreement Addendum No. 2 dated December 31, 2004

EXHIBIT 10.14(b)

 

[LETTERHEAD OF MPI RESEARCH]

 

SERVICES AGREEMENT ADDENDUM No. 2

 

Sponsor: Phage Biotechnology Corporation

Sponsor’s Representative: Jack Jacobs, Ph.D.

Date: December 31, 2004

Study Type: A 4-Week Dermal Toxicity Study of Recombinant Human Growth Factor (FGF-1) in Rats

Study Director: Robert Tawoda

Sponsor’s Study No.:

MPI Research Study No.: 1118-002

MPI Research Proposal No.: 04-082218

Study Schedule:

 

    Estimated Start Date:    December 29, 2004
    Estimated Date of Terminal Necropsy:    January 25, 2005
    Estimated Audited Draft Report Date:    April 20, 2005

 

Study Price:                $50,400 Original

Payment Schedule:

 

    Animal Acquisition    $30,200
    30 Days After Initial Billing    $15,200
    At Mailing of Audited Draft Report    $  5,000

 

THE WORK DESCRIBED IN THIS PROTOCOL WILL BE DONE UNDER THE TERMS AND CONDITIONS OF THE MASTER AGREEMENT BETWEEN MPI RESEARCH AND (Enter Sponsor Here) DATED (Enter Date Here) AND THIS ADDENDUM NO. IS INCORPORATED INTO AND MADE A PART OF SAID MASTER AGREEMENT. MODIFICATIONS TO THE STUDY PRICE, MUTUALLY AGREED UPON IN WRITING BY THE PARTIES, THAT OCCUR DURING THE COURSE OF THE ABOVE DEFINED PAYMENT SCHEDULE WILL BE REFLECTED ON THE NEXT SCHEDULED INVOICE, UNLESS OTHERWISE NOTED.

 

/S/    JACK JACOBS       /S/    ANDREJS DUMPIS
On behalf of (Enter Sponsor Here)       On behalf of MPI Research, Inc.
Date: 1/11/05       Date: 1/5/05